Morning Ag Clips

Scientists with the U.S. Department of Agriculture’s Agriculture Research Service (ARS) have announced that a vaccine candidate for African Swine Fever (ASF) passed an important safety test required for regulatory approval, moving the vaccine one step closer to commercial availability.

The test is an important milestone as part of a series of safety studies. These new results show that USDA’s vaccine candidate does not revert to its normal virulence, after being injected into swine. This “reversion to virulence” test is required to ensure that the vaccine’s weakened form of the ASF virus does not revert to its original state.

Read in full here.